nerandomilast
nerandomilast is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand name including JASCAYD. Available dosage forms: tablet, tablet, film coated.
Drug Details
- Generic Name
- nerandomilast
- Brand Names
- JASCAYD
- Application Number
- NDA218764
- Sponsor
- Boehringer Ingelheim Pharma GmbH and Co. KG
- NDC Codes
- 5
- Dosage Forms
- TABLET, TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- NERANDOMILAST
Indications and Usage
1 INDICATIONS AND USAGE JASCAYD is a phosphodiesterase 4 (PDE4) inhibitor indicated for: The treatment of idiopathic pulmonary fibrosis in adult patients. ( 1.1 ) The treatment of progressive pulmonary fibrosis in adult patients. ( 1.2 ) 1.1 Idiopathic Pulmonary Fibrosis JASCAYD is indicated for the treatment of idiopathic pulmonary fibrosis (IPF) in adult patients. 1.2 Progressive Pulmonary Fibrosis JASCAYD is indicated for the treatment of progressive pulmonary fibrosis (PPF) in adult patients.